Kodu・Aktsiate loetelu・Anika Therapeutics Inc

Anika Therapeutics Inc

Avatud

SektorTervishoid

21.48 2.33

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.57

Max

21.87

Põhinäitajad
By Trading Economics
Sissetulek	8.4M 3.3M
Müük	3M 33M
Aktsiakasum	0.3
Kasumimarginaal	10.147
Töötajad	235
EBITDA	8.3M 4.9M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	-0.8% downside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	4. nov 2026

Turustatistika
By TradingEconomics
Turukapital	78M 277M
Eelmine avamishind	19.15
Eelmine sulgemishind	21.48

Uudiste sentiment

By Acuity

50%

171 / 340 Pingereas Healthcare

Anika Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. aug 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12. aug 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11. aug 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10. aug 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7. aug 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6. aug 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5. aug 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4. aug 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3. aug 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31. juuli 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30. juuli 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29. juuli 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28. juuli 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27. juuli 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24. juuli 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22. juuli 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21. juuli 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20. juuli 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Võrdlus sarnastega

Hinnamuutus

Anika Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

-0.8% langus

12 kuu keskmine prognoos

Keskmine 21 USD -0.8%

Kõrge 21 USD

Madal 21 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Anika Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Anika Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

171 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.